Speakers

Keynote Speaker

Dr. Ramli Zainal
Director, National Pharmaceutical Regulatory Agency (NPRA)


Title: Pharmacy Research in the next 2 years, the way forward

Dr Ramli Zainal is currently the Director of National Pharmaceutical
Regulatory Agency (NPRA). Prior to the present appointment, he is the Director of Pharmacy Policy & Strategic Planning Division, Pharmaceutical Services Division (PSD) Ministry of Health Malaysia.

Dr. Ramli Zainal graduated with a degree in Pharmacy from Universiti Sains Malaysia (USM) and completed a Master’s degree from University of Bradford. He was then awarded a PhD in PharmacoEconomics from USM.

Earlier appointment includes, Head of Healthcare Economic Research Division at the Institute for Health Systems Research (IHSR) and various other positions in the National Pharmaceutical Control Bureau as a GMP Auditor, Head of Cosmetic Unit, Head of Secretariat Unit and Head of Organisational Development & IT Division. He has also worked as a Drug Enforcement Officer in Penang and as a Hospital Pharmacist.

As a researcher, Dr Ramli Zainal is the principle investigator for projects funded by UNDP and the National Institute of Health. He also collaborated in various projects and is actively involved in conducting trainings in the field of economics evaluation in healthcare. He is an expert member to the Ministry of Health Malaysia, PharmacoEconomics Technical Working Group, Health Technology Assessment group and is an appointed member of the Pharmacy Board Malaysia.

He has served the World Health Organisation (WHO) as a consultant for the Training of Trainer in QA/QI in Papua New Guinea and countries within the WHO Western Pacific Regional Office. He is also involved in the training for QA/QI at national level. He is currently the Honorary Secretary to the Malaysian Society for PharmacoEconomics and Outcomes Research (MySPOR) and a member of the Malaysian Pharmaceutical Society (MPS).

Plenary Speakers

Pharmaceutical Technology

Dr. Mohd Cairul Iqbal Mohd AminDr. Mohd Cairul Iqbal Mohd Amin
Professor
Faculty of Pharmacy
Universiti Kebangsaan Malaysia
Kuala Lumpur, Malaysia


Title: From Nature to Clinical: Bacterial Cellulose-based Hydrogel for Wound Injury.

Mohd Cairul Iqbal Mohd Amin earned his BSc (Hons) in Pharmacy in 1996 and PhD in 2001 both from the University of Manchester, United Kingdom. He is currently the Deputy Leader of UKM Grand Challenge for Malaysia Health & Wellness with the responsibility to accelerate translational and high impact research in UKM. His current research interests include responsive-hydrogel biomaterials for oral protein and peptide delivery, cell delivery in tissue engineering and nano drug delivery systems in particular polymeric micellar conjugates for cancer research.

Pharmaceutical Chemistry

Prof. Dr. Shin Aoki
Professor
Faculty of Pharmaceutical Sciences
Tokyo University of Science
Japan


Title: Recent Development of Zinc Chemistry –Zinc Supramolecular Chemistry and Zn-promoted Reactions.

Shin Aoki obtained Ph.D. from the University of Tokyo, Japan, in 1992 and became a professor at Tokyo University of Science in 2003 after research experience at the University of Tokyo, the Scripps Research Institute, and Hiroshima University. His main researches include bioorganic, bioinorganic, medicinal, and supramolecular chemistry.

Dr. Joel Tyndall
Associate Dean (Internationalisation)
University of Otago
Division of Health Sciences
New Zealand


Title: Structure guided small molecule discovery.

Joel Tyndall leads a research group at the University of Otago, New Zealand. He obtained his doctorate from the University of Queensland in drug design in 2000. His research involves drug discovery in the areas of cancer and infectious diseases as well as the understanding of resistance mechanisms in infectious diseases.

Prof. Ong Chi Wi
Professor , Department Of Chemistry
National Sun Yat Sen University, Kaohsiung


Title: Functional Group Interconversion and Chemical Space Manipulation for New Drug Design.

Chi Wi ONG obtained his doctorate from Cambridge (1983). His research focused primarily on applying chemical expertise in the area of functional group transformations and scaffold modifications for the inventive design of new biologically active molecules, especially in the field of genomics and natural products as potential anticancer agents. Other field include synthetic methodology and supramolecular chemistry.

Pharmacy Practice

Prof. Dr. Mohamed Azmi Ahmad Hassali Prof. (Dr.) Mohamed Azmi Ahmad Hassali
Professor of Social and Administrative Pharmacy,
School of Pharmaceutical Sciences,
Universiti Sains Malaysia,
Malaysia


Title:Contribution of Social Pharmacy Field Towards Developing QUM Models: Experience From Malaysia.

Professor Dr. Mohamed Azmi Ahmad Hassali graduated with a Bachelor Degree in Pharmacy from Universiti Sains Malaysia in the year 1998 and a Master’s Degree in the field Clinical Pharmacy from the same university in 2001. In the year 2002, he was selected to receive the ‘Universiti Sains Malaysia Academic Staff Training Fellowship (ASTS)’ to pursue his PhD studies in the field of social pharmacy in Australia. He was successfully awarded with a PhD degree by the Victorian College of Pharmacy, Monash University, Melbourne, Australia in the year 2006.

Assoc. Prof. (Dr.) Surakit Nathisuwan, PharmD, BCPS
Deputy Dean for Planning and Quality Development
Associate Professor in Clinical Pharmacy
Clinical Pharmacy Division
Department of Pharmacy
Faculty of Pharmacy
Mahidol University
Bangkok, THAILAND


Title: Emerging therapies for cardiovascular diseases.

Surakit Nathisuwan received a Doctor of Pharmacy degree (University of Florida) in 1999, Specialized Residency in Pharmacotherapy (University of Texas) and became US Board Certified Pharmacotherapy Specialist in 2001. His main area of teaching and research interest is in cardiovascular pharmacotherapy and pharmacy practice.

Pharmacology

Prof. Dr. Brian L FurmanProf. (Dr.) Brian L Furman
Emeritus Professor of Pharmacology
Strathclyde Institute of Pharmacy &
Biomedical Sciences
161, Cathedral Street
Glasgow G4 ORE


Title: Future treatments for type 2 diabetes.

BPharm PhD DSc (hc); Fellow of the Royal Pharmaceutical Society; Honorary Fellow of the British Pharmacological Society. Dean, Faculty of Science, University of Strathclyde (2002-2008); Emeritus Professor of Pharmacology; Member of the Editorial Boards of Diabetes, Obesity and Metabolism and the Journal of Ethnopharmacology. Research publications in diabetes and obesity.

Invited Speakers

Prof. Chee-Onn Leong, Ph.D., B.Sc.
Deputy Director, Research
International Medical University
Bukit Jalil, Kuala Lumpur,
Malaysia


Title: Data Analytics, Cancer Informatics and Precision Medicine.

Professor Leong has conducted multi-year research focused on cancer biology, drug target discovery, novel molecules development, and biomarkers development for cancers. He was a Senior Research Fellow at the Harvard Medical School and Massachusetts General Hospital, USA and is presently the Deputy Director of the Institute for Research, Development and Innovation (IRDI).

Dr. Bimo Ario TejoDr. Bimo Ario Tejo
Dean of Faculty of Applied Sciences,
UCSI University,
Malaysia


Title: Rational Design of Protein Arginine Deiminase Type IV Inhibitors.

Bimo Ario Tejo obtained his BSc in Chemistry from the University of Indonesia in 1999 and his PhD in Biotechnology from Universiti Putra Malaysia in 2004. He did his postdoctorate in Pharmaceutical Chemistry at the University of Kansas. He is now Dean of Faculty of Applied Sciences, UCSI University. He has almost 20 years of research experience in protein and peptide chemistry, pharmaceutical chemistry, and computational biology. He has published over 50 peer-reviewed papers, presented his work at 60 seminars and conferences, and filed 5 patents out of his work.

Dr. Kazunori AkimotoDr. Kazunori Akimoto
Professor
Tokyo University of Science
Japan


Title: The role of atypical protein kinase C (aPKC) in glycolysis of breast cancer stem cells.

I obtained my doctorate from Tokyo University of Science, in Japan in 1996 and became a professor at Tokyo University of Science in 2018 after research experience at Yokohama City Univ. and Cancer Institute. My research field is signal network system in the area of cancer.

Dr. Tomomi AkitaDr. Tomomi Akita
Assistant Professor
Tokyo University of Science
Japan


Title: Therapeutic strategy based on inducing differentiation for intractable pulmonary disease.

Tomomi Akita obtained Ph.D. from Tokyo University of Science, Japan, and received TUS award 2017 and Ōmura Prize in 2017. She currently is Assistant Professor at Tokyo University of Science. Her special fields are Pharmaceutics and Drug Delivery, Regenerative Medicine.

Dr. Yohei KawanoDr. Yohei Kawano
Assistant Professor
Tokyo University of Science
Japan


Title: Caffeine increases cisplatin-induced apoptosis via inhibition of Akt pathway and ATM-mediated cell cycle checkpoint pathway in HCC cell lines.

Yohei Kawano obtained Ph. D. from University of Miyazaki in 2012, and worked as pharmacist at University of Miyazaki Hospital from 2005 to 2015. Then he became a Assistant professor at Tokyo University of Science in 2016.


Dr. Rie Ozeki
Assistant professor
Tokyo University of Science
Japan


Title: Development of new residency program for Academic Detailing in Japan.

Research field: Clinical Pharmacy.
Dr. Mohd bin Makmor BakryDr. Mohd bin Makmor Bakry
Associate Professor
Deputy Dean for Research and Innovation
Faculty of Pharmacy
Universiti Kebangsaan Malaysia


Title: Innovative Approaches to Improve Medication Adherence.

Mohd bin Makmor Bakry obtained his BPharm (Hons) in 1999 from UKM and PhD in 2007 from the University of Glasgow, Scotland. He was the recipient of the 11th Anugerah Akademik Negara (National Academic Award) in 2017. His current research interests include clinical pharmacy practice and pharmacotherapy in neuromedical illnesses.

Dr. Eugene Ong Boon BengDr. Eugene Ong Boon Beng
Senior Lecturer
Institute for Research in Molecular Medicine (INFORMM)
Universiti Sains Malaysia
Malaysia


Title: The humble yeast: An amazing model for drug discovery.

Eugene obtained his PhD from Universiti Sains Malaysia in 2011 as an Asia Program Associate in RIKEN, Japan in the field of chemical biology. Then, he was a postdoctoral fellow in the Enteric Diseases Research Cluster at INFORMM, USM where he is now a senior lecturer since 2014.

Dr. Chin Fen NEOHDr. Chin Fen NEOH
Senior Lecturer
Faculty of Pharmacy
Universiti Teknologi MARA
Malaysia


Title: Towards timely access to innovative therapies for diseases with unmet medical needs: balancing value and cost.

Chin Fen NEOH completed her PhD at Monash University (Melbourne, Australia) and was awarded the Vice-Chancellor's Commendation for Doctoral Thesis Excellence in 2013. Her research interest is in the field of pharmacoeconomics and outcome research, specifically in infectious diseases, oncology and diabetes mellitus.

Dr. Rajesh Ramasamy, PhDDr. Rajesh Ramasamy, PhD
Immunology Unit, Department of Pathology
Faculty of Medicine and Health Sciences
Universiti Putra Malaysia
Malaysia


Title: Immunomodulatory Functions of Local Medicinal Plants.

Dr Rajesh is an Associate Professor at Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, leads the Stem Cell & Immunity Research Group and Regenerative Medicine Research Program. He received bachelor’s degree in Biomedical Sciences (Immunology) and subsequently completed PhD in Stem Cell Transplantation at Imperial College of London.

Prof. Daryono Hadi Tjahjono, PhD
School of Pharmacy,
Bandung Institute of Technology,
Indonesia.


Title: Do porphyrin derivatives have a prospect for biological application?

Daryono Hadi Tjahjono's research interest is design and synthesis of porphyrin and chlorophyll derivatives as photosensitizer for photodynamic therapy and ligand for radiopharmaceutical, as well as their in silico and in vivo study.

Dr. Cameron Phillips, PhD
Lecturer and Senior Pharmacist
College of Medicine and Public Health
Flinders University, Australia.


Title: Strategies to prolong the utility of the antibiotic vancomycin in an era of antibiotic resistance.

A senior pharmacist at Flinders Medical Centre, a 550-bed teaching hospital in Adelaide, Australia. Cameron holds academic affiliation within the School of Pharmacy, University of South Australia and is an Honorary Research Associate in the Department of Medicine, Imperial College London. His research involves optomising the clinical use of antibiotics.


Dr. Qamar Uddin Ahmed, MSc, PhD
Deputy Dean (Postgraduate Research)
Associate Professor in Pharmaceutical Chemistry
Department of Pharmaceutical Chemistry
Kulliyyah of Pharmacy
International Islamic University Malaysia (IIUM)
Kuantan, Pahang DM, Malaysia


Title: Evaluation of in vitro antidiabetic activity of selected flavonoids: Structure activity relationship based study.

Dr. Qamar U. Ahmed obtained his BSc (Hons.), MSc and PhD (Organic Chemistry) (2002) from Aligarh Muslim University, India. He has been associated with IIUM since 2004. His current research interest is the synthesis and isolation of biologically active compounds and structure activity relationship studies with respect to discover antidiabetic, anticancer and antimicrobial agents.

Prof. Dr. Winnie Chee Siew Swee
Dean, School of Health Sciences
International Medical University


Title: Evidence-based guidelines for Diabetes Management.

Prof Winnie Chee’s research is primarily focused on the nutritional aspects of bone health, Type 2 diabetes, obesity and chronic kidney disease with the objectives to understand the nutritional determinants and interventions in the Asian context. She is currently the President of the Malaysian Dietitians’ Association. Dr Chee also provides consultation as a dietitian in the IMU Medical Clinic, Bukit Jalil, Kuala Lumpur.


Prof. Chu Wan Loy
Dean, School of Postgraduate Studies;
International Medical University

Title: Microalgae as a Potential Source of Bioactive Compounds: Prospects and Challenges

Prof Chu Wan Loy is presently the Dean of the School of Postgraduate Studies, IMU and was the Deputy Director of the Institute for Research, Development and Innovation (IRDI), IMU from 2012- 2017. He also sits on the IMU Joint Committee on Research and Ethics (IMU JC). Prof Chu has been actively involved in Algal Biotechnology research for more than 20 years. Prof Chu, as an active member of the Malaysian Antarctic Research Programme (MARP) went on three expeditions to the Antarctic and Arctic. His research interests cover many aspects of algal biotechnology, ranging from bioactives and nutraceuticals (e.g. anticancer, antiviral and antioxidant compounds) from algae, applications of algae in environmental health (e.g. bioremediation and toxicity testing) to stress adaptation in tropical and polar algae. Prof Chu is presently Executive Council Member of the Asian Pacific Phycological Association (APPA) and was the Honorary Secretary of APPA from 2005-2011. He was also an Associate Member of the Academy of Sciences Malaysia (ASM) from 2012 to 2017.





Luncheon Talk

Luncheon Talk


Dr. Albiruni Ryan Abdul Razak
Medical Oncologist at Princess Margaret Cancer Centre and Mount Sinai Hospital, Toronto

Title: Insights into First-in-Human Studies: An Investigator’s Perspective

Dr. Abdul Razak is an Assistant Professor at the University of Toronto. Clinically, he is a Staff Medical Oncologist in Phase 1 Clinical Trials and Sarcoma at the Princess Margaret Cancer Centre and Mount Sinai Hospital, Toronto. He also leads the Medical Oncology Sarcoma Program at both institutions.

Originally from Malaysia, he underwent medical and oncology training in Ireland, England as well as Canada. He was the recipient several international awards, to include the Young Investigator Award from the American Society of Clinical Oncology (ASCO), Merit Award from the Conquer Cancer Foundation as well as the Mick Knighton Mesothelioma Award from the British Lung Foundation. Dr Abdul Razak was also the inaugural recipient of the Sarcoma Cancer Foundation of Canada Fellowship.

Dr Razak’s main interest is new drug development, especially in the field of sarcoma. He has authored over 80 papers, including in high impact journals such as Journal of Clinical Oncology, Cancer Discovery, Clinical Cancer Research and Cancer. He was also the author of the oncology chapter for Davidson’s Textbook of Medicine (23rd and 24th edition).

Dr. David Reishofer
Management Assistant, Anton Paar

Title: Microwave-assisted Solutions for the Synthesis of Pharmaceutical Products

Sally Pang
Chief Internal Educator, e-beauty group

Title: Microwave-assisted Solutions for the Synthesis of Pharmaceutical Products

Sally Pang is the International CHIEF EDUCATOR with Industries and has the working experience of more than 30 years. She is the Chief Trainer of the World Skills Competition 2003 in Switzerland and the GOLD ,SILVER and BRONZE Medallist Trainer in National Skill Competition year 2003 and 2004. She has a diploma in CIDESCO and Diet & Nutrition for Complementary Therapist (ITEC).